About This Product
Collagen 30 with Biotin from Webber Naturals features 2500 mg of Verisol® Bioactive Collagen Peptides™ enhanced with 5000 mcg of biotin per serving for advanced nourishment of skin, hair, and nails. This dynamic duo promotes beauty from within, helping to reduce deep wrinkles for younger looking skin, and strengthen hair and nails in less than 30 days.
- Stimulates skin cell renewal to reduce fine facial lines and eye wrinkles
- Promotes collagen and elastin production for smoother, more youthful looking skin
- Made with clinically researched Verisol bioactive collagen peptides
- Formulated with biotin to promote healthy, shiny hair and strong nails
- Convenient 3 tablets serving daily
Collagen 30 with Biotin from Webber Naturals features Verisol, a unique complex collagen peptide providing type I and type III hydrolyzed collagen, alongside biotin, an essential vitamin for healthy skin, hair, and nails. Taking a daily dose of 2500–5000 mcg of biotin helps enhance the thickness and strength of hair and nails, helping to prevent painful nail splitting.
As the body’s most abundant protein, collagen is also essential for the proper structure of healthy skin, hair, nails, bones, and joints. Collagen makes up 75% of the dry mass of the dermis, but collagen synthesis declines dramatically as we age and collagen is degraded by micro-trauma, ultraviolet light (sun) exposure, smoking, and soft tissue injury. A lack of collagen causes skin to become thin, dry, saggy, and weak, resulting in visible signs of aging, including wrinkles and fine lines.
Verisol stimulates skin cells to produce collagen and elastin, promoting healthier, younger-looking skin. By increasing collagen and elastin in skin, Verisol enhances skin moisture and elasticity, and can reduce deep wrinkles within 30 days.
Collagen 30 with Biotin provides effective daily support for healthy skin, hair, and nails, promoting natural beauty from the inside out.
(Adults): 1 tablet 3 times daily or as directed by a physician.
Reviews
There are no reviews yet.